Ciclesonide and glycopyrronium combination
AssigneeAltana Pharma AG
InventorsRene Roscher, Christoph Karl
Life of this patent
Estimating the term…
Abstract
The invention relates to pharmaceutical formulations containing combinations of ciclesonide and a pharmaceutically acceptable salt of glycopyrronium and the use of such pharmaceutical compositions in medicine, in particular in the prophylaxis and treatment of respiratory disease.
Claims19
A pharmaceutical formulation comprising a pharmaceutical acceptable salt of glycopyrronium, a solvate or physiologically functional derivative thereof in combination with ciclesonide, a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof and a pharmaceutically acceptable carrier and/or one or more excipients.
A method of treatment of a clinical condition in a mammal, for which a corticosteroid and/or an anticholinergic agent is indicated, which comprises administration of a therapeutically effective amount of a pharmaceutical formulation comprising ciclesonide or a pharmaceutical acceptable salt, solvate, or physiologically functional derivative thereof in combination with a pharmaceutical acceptable salt of glycopyrronium, a solvate, or physiologically functional derivative thereof, and a pharmaceutical acceptable carrier and/or one or more excipients.
Dependencies are inferred from the claim text.